Correct me if I'm wrong but it seems that the VRX short case is
-VRX did something wrong through Phillidor or another speciality pharma
-Phillidor will be heavily fined
-This fine will flow through Phillidor and VRX will have to pay. Because they are levered 4-1 they are in huge trouble
Its a series of low probabilities events that all have to happen. First what Phillidor did has to be illegal (not just aggressive), who to trust, the army of lawyers VRX has or shorts with 0 legal training? Then it must lead to a big fine (I mean really big because its just a one time thing, one thing charges should not impact the valuation of a stock significantly unless they are huge and threaten liquidity/business model). Then the Phillidor structure will have to be deemed invalid so VRX becomes liable for the fine (which the army of lawyers at VRX says they do not think will happen)
All of this will have to happen, if any of them doesn't, then the stock is a buy. This thesis might have been good at $160 but at $110, frankly, I just think its ridiculous. Price matters
Recent events has shred more light on is likely to happen to VRX. The company has walked away from Philidor (which means they did illegal things in all likelyhood). Philidor will be potentially target from lawsuits (specially given they they are tied to a very politically unpopular Valeant and also those illegal things made the front page of the WSJ many days in a row). That liability MIGHT flow through Valeant or it might not but 2 points of my initial thesis have been shown to be breached. At this point it all comes down to how strong was the entity built to shield them from liabilities (and whether those liabilities will be big enough to kill VRX). At this point its too dangerous for me to continue in the stock so I plan to sell my PSH (ackman fund that has a lot of VRX exposure) into the pop he is likely to create today